FSH: When to Order This Test and What Your Results Mean

What FSH Is and Why It Matters

Follicle-stimulating hormone is a glycoprotein secreted by gonadotroph cells in the anterior pituitary gland. It acts directly on the gonads. In women, FSH drives follicular recruitment and estradiol production in the ovaries. In men, it supports Sertoli cell function and spermatogenesis in the testes.

The Hypothalamic-Pituitary-Gonadal Axis

The hypothalamus releases gonadotropin-releasing hormone (GnRH) in a pulsatile pattern, which triggers the pituitary to secrete both FSH and luteinizing hormone (LH). Estradiol and inhibin B from the ovaries feed back to suppress FSH secretion [1]. When ovarian function declines (fewer follicles producing estradiol and inhibin), that brake weakens. FSH rises. This feedback loop is the reason a high FSH reading reliably signals diminished ovarian reserve or menopause.

FSH vs. LH: Different Signals

LH and FSH are released together, but they do different things. LH triggers ovulation and stimulates testosterone production. FSH promotes follicle growth and sperm maturation. The FSH-to-LH ratio can also help diagnose polycystic ovary syndrome (PCOS), where LH is often disproportionately elevated relative to FSH [2]. Ordering both hormones together gives clinicians a more complete picture of the pituitary-gonadal axis than either test alone.

When Clinicians Order an FSH Test

The short answer: FSH is ordered whenever a clinician suspects the ovaries, testes, or pituitary gland are not functioning normally. The Endocrine Society's 2015 clinical practice guideline on primary ovarian insufficiency recommends measuring serum FSH (along with estradiol) as a first-line diagnostic step in women under 40 with unexplained amenorrhea or oligomenorrhea lasting four or more months [3].

Evaluating Irregular or Absent Periods

Women presenting with secondary amenorrhea (absence of menses for three or more consecutive cycles) should receive an FSH and estradiol draw after pregnancy is excluded. An FSH above 25 IU/L measured twice, at least one month apart, confirms primary ovarian insufficiency (POI) in women under 40 [3]. This threshold was established because values above it indicate the pituitary is maximally attempting to stimulate follicles that no longer respond.

Confirming Perimenopause and Menopause

The 2022 North American Menopause Society (NAMS) position statement notes that menopause is a clinical diagnosis based on 12 months of amenorrhea in women over 45, and routine FSH testing is not required in that straightforward scenario [4]. FSH testing becomes valuable in ambiguous cases. A 46-year-old with a hysterectomy but intact ovaries cannot use menstrual history as a guide, so FSH above 30 IU/L helps confirm menopausal status before initiating hormone therapy.

Fertility Assessment

Reproductive endocrinologists measure day-3 FSH as part of the ovarian reserve workup before IVF. The American Society for Reproductive Medicine (ASRM) practice committee states that a day-3 FSH above 10 IU/L (when paired with an estradiol above 60 to 80 pg/mL) may indicate reduced ovarian reserve and a lower expected response to gonadotropin stimulation [5]. Anti-Müllerian hormone (AMH) and antral follicle count have partially supplanted day-3 FSH in modern IVF protocols, but FSH remains widely used because it is inexpensive and universally available.

Male Hypogonadism Workup

The Endocrine Society's 2018 guideline on testosterone therapy recommends measuring LH and FSH when serum total testosterone is confirmed low on two morning draws [6]. The distinction matters for treatment. High FSH with low testosterone indicates primary testicular failure (hypergonadotropic hypogonadism). Low or inappropriately normal FSH with low testosterone points to a pituitary or hypothalamic cause (hypogonadotropic hypogonadism) that may warrant MRI imaging of the sella turcica.

Delayed or Precocious Puberty

Pediatric endocrinologists order FSH and LH to differentiate central precocious puberty (early activation of the hypothalamic-pituitary axis) from peripheral causes. In delayed puberty, a low FSH may indicate constitutional delay, while a very high FSH in a teenage girl with absent breast development suggests gonadal dysgenesis, such as Turner syndrome [7].

Pituitary Tumors and Hypopituitarism

An inappropriately low FSH in the setting of hypogonadal symptoms can indicate a pituitary adenoma compressing gonadotroph cells or infiltrative disease affecting the pituitary stalk. The American Association of Clinical Endocrinologists (AACE) recommends a full anterior pituitary hormone panel (including FSH, LH, TSH, prolactin, cortisol, and IGF-1) when pituitary pathology is suspected [8].

How to Prepare for an FSH Blood Test

Preparation is minimal, but timing is everything for premenopausal women. The test should be drawn on cycle day 2 or 3 (counting from the first day of full menstrual flow). Drawing later in the follicular phase can produce misleadingly low values because rising estradiol from the dominant follicle suppresses FSH. Men and postmenopausal women can be tested on any day.

Practical Considerations

Fasting is not required, though some clinicians prefer a morning draw because FSH has mild diurnal variation. Biotin supplements at doses above 5,000 mcg per day can interfere with certain immunoassay platforms and should be stopped at least 72 hours before testing [9]. Hormonal contraceptives suppress the hypothalamic-pituitary axis, so FSH drawn while on combined oral contraceptives does not reflect endogenous function. Clinicians typically ask patients to stop hormonal contraception for at least one full cycle before ordering a diagnostic FSH.

What to Order Alongside FSH

A lone FSH value has limited diagnostic power. The standard companion panel includes estradiol (to contextualize the FSH reading), LH (to evaluate the FSH-to-LH ratio), and often AMH (for ovarian reserve). In male patients, a simultaneous total testosterone, free testosterone, and LH draw rounds out the initial workup. For pituitary evaluations, prolactin and TSH are added.

Normal FSH Ranges by Age and Sex

Reference ranges vary slightly between laboratories, but the following values reflect consensus ranges reported by major reference labs and the Endocrine Society [1][6].

Premenopausal women (follicular phase): 3.5 to 12.5 IU/L. Mid-cycle surge values can reach 4.7 to 21.5 IU/L. Luteal phase values typically fall between 1.7 and 7.7 IU/L.

Postmenopausal women: 25.8 to 134.8 IU/L. The wide range reflects individual variation in time since menopause and residual ovarian activity.

Adult men: 1.5 to 12.4 IU/L. Values remain relatively stable from age 20 through 60, with a gradual increase thereafter.

Prepubertal children: typically <4 IU/L in both sexes.

Dr. Nanette Santoro, professor of obstetrics and gynecology at the University of Colorado School of Medicine and lead author of the SWAN (Study of Women's Health Across the Nation) FSH analyses, has noted: "A single FSH value is a snapshot. FSH fluctuates considerably during the menopausal transition, and a value of 20 IU/L one month can be followed by 8 IU/L the next" [10]. This variability is precisely why guidelines require two elevated readings at least four weeks apart before diagnosing POI.

What High FSH Means

Elevated FSH tells you the pituitary is working overtime because the gonads are not producing enough sex hormones to complete the feedback loop. The clinical significance depends on the patient's age, sex, and reproductive context.

High FSH in Women Under 40

Two FSH values above 25 IU/L, drawn at least one month apart in a woman under 40 with oligo- or amenorrhea, meet the Endocrine Society's diagnostic criteria for primary ovarian insufficiency [3]. POI affects approximately 1% of women under age 40 and 0.1% under age 30 [3]. Autoimmune causes (often associated with thyroid autoimmunity or adrenal insufficiency) account for roughly 4% to 30% of cases depending on the population studied [11].

High FSH in Perimenopausal and Postmenopausal Women

FSH rises progressively during the menopausal transition. SWAN data from 3,302 women showed that FSH began increasing approximately 2 years before the final menstrual period and peaked roughly 2 years after, with a median peak of approximately 80 IU/L [10]. An FSH above 30 IU/L in a symptomatic woman over 45 supports a clinical menopause diagnosis, but as NAMS emphasizes, blood testing is not needed when the clinical picture is clear [4].

High FSH in Men

An FSH above 12 to 15 IU/L in a man with low testosterone and/or abnormal semen parameters suggests primary testicular failure. Causes include Klinefelter syndrome (47,XXY), prior chemotherapy, mumps orchitis, and cryptorchidism. The 2020 AUA/ASRM guideline on male infertility recommends FSH measurement as part of the initial evaluation for men with semen abnormalities, because an FSH more than twice the upper limit of normal predicts severe spermatogenic failure [12].

What Low FSH Means

Low FSH signals that the pituitary is underproducing gonadotropins. This is called hypogonadotropic hypogonadism, and the problem originates above the gonads.

Hypothalamic Causes

Functional hypothalamic amenorrhea (FHA) is the most common cause of low FSH in young women. Energy deficit from excessive exercise, low body weight, or psychological stress suppresses GnRH pulsatility. The Endocrine Society's 2017 guideline on FHA states that low or low-normal FSH, low LH, and low estradiol in a woman with amenorrhea and no structural pituitary lesion, after exclusion of other causes, supports the diagnosis [13]. Recovery of FSH secretion follows correction of the energy deficit.

Pituitary Causes

Pituitary adenomas (particularly prolactinomas), pituitary apoplexy, and infiltrative diseases such as hemochromatosis or sarcoidosis can suppress FSH production. An inappropriately low FSH paired with clinical hypogonadism warrants pituitary MRI. Dr. Shlomo Melmed, senior vice president of academic affairs at Cedars-Sinai and editor of Williams Textbook of Endocrinology, has written: "Gonadotropin deficiency is often the earliest hormonal casualty of a growing pituitary mass, because gonadotroph cells are among the most sensitive to compression" [14].

Medication-Induced Suppression

Exogenous testosterone, anabolic steroids, GnRH agonists (leuprolide), and high-dose opioids all suppress FSH through negative feedback. Men on testosterone replacement therapy (TRT) will have suppressed FSH and LH as an expected pharmacologic effect, not a pathologic finding [6]. FSH suppression on TRT also means reduced or absent spermatogenesis, which is why the Endocrine Society recommends against TRT in men actively pursuing fertility.

How to Interpret FSH in Clinical Context

A number without context means little. Interpretation requires knowing the patient's age, menstrual status, medication list, and what other labs were drawn at the same time.

The Day-3 FSH and Estradiol Pairing

A day-3 FSH of 9 IU/L looks normal, but if the paired estradiol is 75 pg/mL, the picture changes. That estradiol level is prematurely elevated, suggesting an advanced follicle is already producing estrogen and artificially suppressing FSH. The "true" unstimulated FSH might be higher. ASRM guidelines flag this combination as suspicious for diminished ovarian reserve even when FSH appears within the reference range [5].

FSH-to-LH Ratio

In a normal menstrual cycle, the FSH-to-LH ratio is close to 1:1 during the early follicular phase. A ratio below 1:2 (meaning LH is more than double FSH) raises suspicion for PCOS, though this finding alone is neither sensitive nor specific enough for diagnosis [2]. The Rotterdam criteria for PCOS do not include the FSH-to-LH ratio as a required criterion, but many clinicians still find it a useful supporting data point.

Serial FSH Monitoring

A single FSH is a snapshot. Serial measurements over two to three cycles provide a trend that is far more informative. The STRAW+10 staging system for reproductive aging uses FSH levels (along with menstrual cycle characteristics and AMH) to classify women into stages from peak reproductive years through late postmenopause [15]. An FSH rising from 8 to 15 to 22 IU/L over six months tells a different story than a single reading of 15 IU/L.

Can You Lower or Raise FSH?

Patients frequently search for ways to modify their FSH levels. The answer depends on what is driving the abnormality.

Lowering High FSH

Because high FSH is a response to low ovarian or testicular output, directly lowering FSH without addressing the underlying cause has no clinical benefit. Estrogen-containing hormone therapy will lower FSH by restoring the feedback signal, but this does not reverse ovarian aging or restore fertility. Some fertility clinics use estradiol priming protocols before IVF cycles specifically to bring FSH down before stimulation, based on the theory that lower baseline FSH improves follicular response to exogenous gonadotropins [5].

Supplements marketed to "lower FSH" (DHEA, CoQ10, vitamin D) may support general ovarian health, but no randomized controlled trial has demonstrated that they reliably reduce FSH levels or improve pregnancy rates in women with POI. A 2018 Cochrane review on DHEA supplementation before IVF found very-low-certainty evidence for improved live birth rates, and the authors concluded that larger trials are needed before recommending routine use [16].

Raising Low FSH

When low FSH results from hypothalamic suppression, the fix is removing the cause. Correcting energy deficit in FHA, treating hyperprolactinemia with cabergoline, or discontinuing exogenous testosterone all allow FSH to recover. In men with hypogonadotropic hypogonadism who want to preserve or restore fertility, clinicians prescribe clomiphene citrate or human chorionic gonadotropin (hCG), sometimes combined with recombinant FSH injections, to stimulate spermatogenesis [6].

Pulsatile GnRH pump therapy is the most physiologic approach to restoring FSH and LH in patients with GnRH deficiency (Kallmann syndrome or idiopathic hypogonadotropic hypogonadism) and has shown ovulation induction success rates above 90% per cycle in carefully selected patients [17].

When to Retest FSH

Retesting timing depends on the clinical question. For POI diagnosis, repeat the draw at least four weeks after the initial elevated result [3]. For fertility monitoring, cycle day 2 or 3 FSH is typically repeated each treatment cycle. For men on clomiphene citrate for hypogonadotropic hypogonadism, FSH is rechecked at 8 to 12 weeks to assess response. Postmenopausal women stable on HRT rarely need repeat FSH testing because the clinical goal is symptom control, not a target FSH number.

Patients stopping hormonal contraception should wait at least one full menstrual cycle (or 6 to 8 weeks if cycles have not resumed) before drawing FSH for diagnostic purposes. The pituitary needs time to re-establish endogenous pulsatile GnRH signaling after suppression.